2021 Pharmaceutical Contract Manufacturing Industry Mergers and Acquisitions Report: Supplier Performance Benchmarking, Market Trends, Competitive Intelligence

DUBLIN, July 16, 2021 / PRNewswire / – Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry – Implications and Outlook – 2021 Edition has been added to ResearchAndMarkets.com’s offering.

This report marks the third edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry.

This report provides important, expert knowledge that you will not find in any other source. 28 tables and figures throughout the report illustrate key points and trends.

scope

This report is required reading for:

  • CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking
  • Bio / Pharma: benchmarking of supplier performance, market trends, competitive information
  • Private equity and equity analysts: target identification and analysis, performance benchmarking of portfolio companies

Reasons to buy

  • Overview of M&A in the pharmaceutical CMO industry
  • Detailed view of CDMO performance by number of closed deals from the publisher’s deals database
  • Analysis of the M&A of specific manufacturing services

Key topics covered:

Summary

Industry analysis

  • Goals and methodology
  • Overview of M&A activities 2018-2020
  • Target features
  • Acquirer Properties
  • Geography
  • Top buyer

Segment close-ups of M&A activity, 2018-2020

  • API biologic
  • API small molecule
  • Commercial dose manufacturing
  • Analytical services
  • packaging
  • Deal advisor
  • Top financial advisor
  • Top legal advisor

reviews

  • Asset acquisitions
  • What it means
  • The outlook for M&A
  • API biological targets
  • Previous predictions
  • Value chain
  • Companies

appendix

Please visit https://www.researchandmarkets.com/r/8jpwxb for more information on this report

Media contact:

Research and Markets
Laura wood, Senior manager
[email protected]

For EST office hours, call + 1-917-300-0470. at
For US / CAN toll free call + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900. at

US Fax: 646-607-1904
Fax (outside the US): + 353-1-481-1716

Cision View original content: https://www.prnewswire.com/news-releases/2021-pharmaceutical-contract-manufacturing-industry-mergers-and-acquisitions-report-supplier-performance-benchmarking-market-trends-competitive-intelligence- 301335730 .html

SOURCE Research and Markets

Comments are closed.